To identify biological mechanisms of action or elucidate biomarkers, you can’t afford to settle for risk scores or potential functionality. You need a technology that integrates genetics, lifestyle, and environment in any sample type, while offering the ability to make discoveries and measure quantitative biomarkers.
Across any application area or disease indication, semi-targeted metabolomics and multiomic data integration solutions from Arome Sciences will provide you with the data you need to bring your product to market.
When designing a metabolomics study, scientists typically decide between platforms that enable discovery and those that quantitatively measure biomarkers.
Arome Science has pioneered a unique semi-targeted approach, offering both discovery and biomarker analysis in the same experiment.
| Feature | Targeted (MRM) | Arome Semi-Targeted | Untargeted (Discovery) |
| Goal | Exact Quantification | Quant + Discovery | Hypothesis Generation |
| Coverage | 20-100 compounds | 1,250+ compounds | 3,000+ features |
| Quantification | Absolute | Tiered (Level 1-3) | Relative (Fold Change) |
| Unknowns | Ignored | Captured (Level 2-4) | Focus Area |
1250+ microbiome and
human-related metabolites (Level 1)
6500+ IDs (Level 2)
State-of-the-art metabolomics
Biomarker elucidation, analysis, & microbiome
multiomics integration bioinformatics
Drug & consumer product development and clinical biomarkers
We recognize that every study is different. Choose the metabolite coverage, specimen type, study design, and bioinformatics analysis you need to succeed. Costs are approximate, and the offerings list is not exhaustive. Metabolite annotations include:
